Literature DB >> 20673324

Persistent alveolar soft-part sarcoma with liver metastasis: a case report.

Olugbenga A Silas1, Adeyi A Adoga, Agabus N Manasseh, Godwin O Echejoh, Raymond A Vhriterhire, Barnabas M Mandong.   

Abstract

INTRODUCTION: Alveolar soft-part sarcomas are rare, slow-growing tumors that metastasize commonly via vascular routes to the lungs, bones, lymph nodes and brain, causing morbidity and mortality. To the best of our knowledge, this is the first case describing metastasis to the liver reported from Nigeria. CASE
PRESENTATION: A 57-year-old man of the Urhobo ethnic group of Nigeria presented with a persistent mass in his left calf. It was initially diagnosed as soft-tissue sarcoma, and its associated systemic effects lead to his death before a histological diagnosis could be obtained.
CONCLUSIONS: Alveolar soft-part sarcoma with metastasis to the liver can occur in our region (northeast Africa), and a high index of suspicion is required to make an early diagnosis, followed by prompt surgical excision with clear margins in order to prevent mortality.

Entities:  

Year:  2010        PMID: 20673324      PMCID: PMC2922299          DOI: 10.1186/1752-1947-4-233

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  12 in total

Review 1.  Chromosome rearrangement at 17q25 and xp11.2 in alveolar soft-part sarcoma: A case report and review of the literature.

Authors:  S Joyama; T Ueda; K Shimizu; I Kudawara; M Mano; H Funai; K Takemura; H Yoshikawa
Journal:  Cancer       Date:  1999-10-01       Impact factor: 6.860

2.  Clinical presentation, treatment, and outcome of alveolar soft part sarcoma in children, adolescents, and young adults.

Authors:  Mark L Kayton; Paul Meyers; Leonard H Wexler; William L Gerald; Michael P LaQuaglia
Journal:  J Pediatr Surg       Date:  2006-01       Impact factor: 2.545

3.  The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.

Authors:  M Ladanyi; M Y Lui; C R Antonescu; A Krause-Boehm; A Meindl; P Argani; J H Healey; T Ueda; H Yoshikawa; A Meloni-Ehrig; P H Sorensen; F Mertens; N Mandahl; H van den Berghe; R Sciot; P Dal Cin; J Bridge
Journal:  Oncogene       Date:  2001-01-04       Impact factor: 9.867

4.  [The histogenesis of alveolar soft part sarcoma: a clinicopathological analysis of 135 cases].

Authors:  R Y Zhang
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  1990-09

Review 5.  Alveolar soft-part sarcoma: a review and update.

Authors:  A L Folpe; A T Deyrup
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

6.  Alveolar soft-part sarcoma. A clinico-pathologic study of half a century.

Authors:  P H Lieberman; M F Brennan; M Kimmel; R A Erlandson; P Garin-Chesa; B Y Flehinger
Journal:  Cancer       Date:  1989-01-01       Impact factor: 6.860

7.  Epidemiology of soft tissue sarcomas in Jos, North Central Nigeria.

Authors:  B M Mandong; A T Kidmas; A N Manasseh; G O Echejoh; M N Tanko; A J K Madaki
Journal:  Niger J Med       Date:  2007 Jul-Sep

8.  Spontaneous regression in alveolar soft part sarcoma: case report and literature review.

Authors:  Mohammed N BaniHani; Abdel Rahman A Al Manasra
Journal:  World J Surg Oncol       Date:  2009-06-10       Impact factor: 2.754

9.  Gene expression profiling of alveolar soft-part sarcoma (ASPS).

Authors:  Luke H Stockwin; David T Vistica; Susan Kenney; David S Schrump; Donna O Butcher; Mark Raffeld; Robert H Shoemaker
Journal:  BMC Cancer       Date:  2009-01-15       Impact factor: 4.430

10.  Alveolar soft part sarcoma: clinicopathological findings in a series of 11 cases.

Authors:  Adrien Daigeler; Cornelius Kuhnen; Joerg Hauser; Ole Goertz; Daniel Tilkorn; Lars Steinstraesser; Hans-Ulrich Steinau; Marcus Lehnhardt
Journal:  World J Surg Oncol       Date:  2008-07-01       Impact factor: 2.754

View more
  1 in total

1.  The use of Latin terminology in medical case reports: quantitative, structural, and thematic analysis.

Authors:  Yuliia V Lysanets; Olena M Bieliaieva
Journal:  J Med Case Rep       Date:  2018-02-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.